Botterweck AA, Verhagen H, Goldbohm RA, et al. Intake of butylated hydroxyanisole and butylated hydroxytoluene and stomach cancer risk: results from analyses in the Netherlands Cohort Study. Food Chem Toxicol 2000;38:599-605.. View abstract.

Coohill TP, Babich M, Taylor WD, Snipes W. A comparison of herpes simplex virus plaque development after viral treatment with anti-DNA or antilipid agents. Biophys J 1980;30:517-21.. View abstract.

Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182

Freeman DJ, Wenerstrom G, Spruance SL. Treatment of recurrent herpes simplex labialis with topical butylated hydroxytoluene. Clin Pharmacol Ther 1985;38:56-9.. View abstract.

Grogan MW. Toxicity from BHT ingestion. West J Med 1986;145:245-6.

Reimund E. Butylated hydroxytoluene, lipid-enveloped viruses, and AIDS. Med Hypotheses 1987;23:39-42.. View abstract.

Shlian DM, Goldstone J. More on BHT toxicity. West J Med 1986;145:699.

Shlian DM, Goldstone J. Toxicity of butylated hydroxytoluene. N Engl J Med 1986;314:648-9.

Williams GM, Iatropoulos MJ, Whysner J. Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives. Food Chem Toxicol 1999;37:1027-38.. View abstract.